A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
Podcast 2: The Role of GLP-1 receptor Agonists in the Care of Patients with Type 2 Diabetes
Post-Test/Evaluation

Questions marked with a * are required
24%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
According to the ADA, higher efficacy approaches have greater likelihood of achieving glycemic goals in patients with type 2 diabetes. Which of the following medications does not have a high efficacy for glucose lowering?
Which of the following patients should not receive GLP-1 receptor agonists?
Personalizing diabetes care involves communicating with the patient and aligning regarding __________.
Powered by QuestionPro